abstract |
The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target ApoC3 and ANGPTL3 expression, lipid particles comprising one or more ( e.g ., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles ( e.g ., for treating hypertriglyceridemia in humans). |